image
Innate Pharma S.A. IPHA
Healthcare - Biotechnology - NASDAQ - FR
Watchlist
$ 2.1264
0.302 %
$ 178 M
Market Cap
-4.83
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 4.56% 92.36% -8.74%
Annual Report FY 10-K 2022-12-31 309.83% -67.58% 75.64%
Annual Report FY 10-K 2021-12-31 -82.64% 7.58% -4432.34%
Annual Report FY 10-K 2020-12-31 1.16% -205.19% 103.99%
Annual Report FY 10-K 2019-12-31 -13.67% -687.60% -525.71%
Annual Report FY 10-K 2018-12-31 144.83% 106.30% 112.87%
Annual Report FY 10-K 2017-12-31 -41.90% -382.79% -528.11%
Annual Report FY 10-K 2016-12-31 213.64% 288.49% 170.28%
Annual Report FY 10-K 2015-12-31 1874.20% 65.87% 46.05%
Annual Report FY 10-K 2014-12-31 -92.73% -579.36% -614.86%
Annual Report FY 10-K 2013-12-31 20.16% 9.60% 17.51%
Annual Report FY 10-K 2012-12-31 -11.61% 54.17% 55.27%
Annual Report FY 10-K 2011-12-31 171.76% 48.89% 44.70%
Annual Report FY 10-K 2010-12-31 -44.01% 6.62% 11.88%
Annual Report FY 10-K 2009-12-31 -40.30% -48.46% -41.15%
Annual Report FY 10-K 2008-12-31 -9.56% -10.47% -21.06%
Annual Report FY 10-K 2007-12-31 130.67% -47.60% -25.58%
Annual Report FY 10-K 2006-12-31 376.54% 1.42% -12.84%
Annual Report FY 10-K 2005-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 -70.09% -392.89% -630.25%
Quarterly Report Q4 8-K 2023-12-31 667.74% 68.07% 60.29%
Quarterly Report Q2 8-K 2023-06-30 279.27% 107.24% 80.24%
Quarterly Report Q4 8-K 2022-12-31 -69.22% -20.05% -65.43%
Quarterly Report Q2 8-K 2022-06-30 12.32% 160.99% 150.01%
Quarterly Report Q4 8-K 2021-12-31 -83.94% 14.44% 25.46%
Quarterly Report Q2 8-K 2021-06-30 -81.94% -179.15% -465.56%
Quarterly Report Q4 8-K 2020-12-31 -61.96% -295.32% -86.85%
Quarterly Report Q2 8-K 2020-06-30 59.79% 31.64% 43.98%
Quarterly Report Q4 8-K 2019-12-31 -23.61% -35.85% -90.59%
Quarterly Report Q2 8-K 2019-06-30 142.49% 156.68% 131.31%
Quarterly Report Q4 8-K 2018-12-31 57.55% 14.90% 90.97%
Quarterly Report Q2 8-K 2018-06-30 11.17% -376.76% -409.12%
Quarterly Report Q4 8-K 2017-12-31 11.01% -1895.91% -31523.19%
Quarterly Report Q2 8-K 2017-06-30 358.49% -191.04% -68.15%
Quarterly Report Q4 8-K 2016-12-31 1191.91% 249.05% 196.28%
Quarterly Report Q2 8-K 2016-06-30 400.00% 64.92% 67.70%
Quarterly Report Q4 8-K 2015-12-31 111.94% 331.99% 111.24%
Quarterly Report Q2 8-K 2015-06-30 -33.51% -245.50% -398.25%
Quarterly Report Q4 8-K 2014-12-31 -46.88% -800.51% -822.50%
Quarterly Report Q2 8-K 2014-06-30 -29.52% -159.00% -139.42%
Quarterly Report Q4 8-K 2013-12-31 64.79% 83.70% 83.78%
Quarterly Report Q2 8-K 2013-06-30 223.06% 65.98% 68.21%
Quarterly Report Q4 8-K 2012-12-31 203.84% 82.75% 82.73%
Quarterly Report Q4 8-K 2011-12-31 52.15% 52.28% 51.27%
Quarterly Report Q2 8-K 2011-06-30 52.15% 52.28% 51.27%
Quarterly Report Q4 8-K 2010-12-31 -66.57% -38.63% -24.39%
Quarterly Report Q2 8-K 2010-06-30 -66.57% -38.63% -24.39%
Quarterly Report Q4 8-K 2009-12-31 -46.00% -64.01% -70.88%
Quarterly Report Q2 8-K 2009-06-30 -46.00% -64.01% -70.88%
Quarterly Report Q4 8-K 2008-12-31 108.62% -63.06% -52.04%
Quarterly Report Q2 8-K 2008-06-30 108.62% -63.06% -52.04%
Quarterly Report Q4 8-K 2007-12-31 999.23% -45.50% -41.71%
Quarterly Report Q2 8-K 2007-06-30 999.23% -45.50% -41.71%
Quarterly Report Q4 8-K 2006-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2006-06-30 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2005-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2005-06-30 0.00% 0.00% 0.00%